We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 164 results
  1. Indicators of Immune and Neurohumoral Profile in Women of Fertile Age with Functional Disorders of the Autonomic Nervous System Associated with Polymorphic Variants of the HTR2A (rs7997012) and TP53 (rs1042522) Genes

    In women of fertile age with functional disorders of the autonomic nervous system (ANS), a complex of indicators of the immune and neurohumoral...

    O. V. Dolgikh, N. V. Zaitseva, ... V. B. Alekseev in Bulletin of Experimental Biology and Medicine
    Article 23 June 2022
  2. Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case–Control Study and In Silico Analyses

    Polycystic ovarian syndrome (PCOS) is a complex endocrine and metabolic condition with several potential causes. Insulin resistance is a hallmark of...

    Ghazaleh Biglari-Zadeh, Saman Sargazi, ... Shekoufeh Mirinejad in Biochemical Genetics
    Article 01 March 2023
  3. Association Between Genetic Variants in the lncRNA–p53 Regulatory Network and Ischemic Stroke Prognosis

    Long noncoding RNAs (lncRNAs) serve as regulators or effectors of the p53 regulatory pathway. The lncRNA–p53 regulatory network plays an important...

    Xu Liu, Lu Wang, ... Ruixia Zhu in Neurotoxicity Research
    Article 02 April 2021
  4. Association of Polymorphic Markers of the TP53, MDM2, and CDKN1A Genes with the Risk of Ovarian Cancer

    Abstract

    The distribution of allele frequencies of polymorphic markers of the genes of the apoptosis and cell cycle control system TP53 (rs1042522), MDM2...

    P. K. Brenner, M. A. Kapralova, ... T. M. Zavarykina in Russian Journal of Genetics
    Article 13 September 2022
  5. Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population

    Background

    Results regarding whether it is essential to incorporate genetic variants into risk prediction models for esophageal cancer (EC) are...

    Haiyan Liu, Keming Li, ... Peng Wang in BMC Cancer
    Article Open access 16 May 2024
  6. Triple Haplotypes of the TP53 Gene in Patients with Diffuse Small B-Cell Lymphoma

    Abstract

    The role of genetic susceptibility to the development of lymphoma is confirmed by the accumulating data on common genetic variants of the...

    E. N. Voropaeva, N. V. Cherdyntseva, ... T. A. Ageeva in Russian Journal of Genetics
    Article 01 December 2019
  7. TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome

    Corticotroph macroadenomas are rare but difficult to manage intracranial neoplasms. Mutations in the two Cushing’s disease mutational hotspots USP8 ...

    Luis Gustavo Perez-Rivas, Julia Simon, ... Marily Theodoropoulou in Acta Neuropathologica Communications
    Article Open access 19 September 2022
  8. Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women

    Background

    Preeclampsia (PE), as a multisystem disorder, is associated with maternal hypertension and proteinuria. Apoptosis seems to be involved in...

    Mahdiyeh Harati-Sadegh, Leila Kohan, ... Saeedeh Salimi in Journal of Biomedical Science
    Article Open access 08 November 2019
  9. Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer

    Locoregional recurrences represent a frequently unexpected problem in head and neck squamous cell carcinoma (HNSCC). Relapse often (10–30%) occurs in...

    Federica Ganci, Matteo Allegretti, ... Giovanni Blandino in Biomarker Research
    Article Open access 05 March 2024
  10. TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population

    TP53 has been reported to be involved in diverse neurological processes related to the pathogenesis of psychosis. In this study, we aim to determine...

    Jialei Yang, Xulong Wu, ... Li Su in Journal of Molecular Neuroscience
    Article 05 May 2019
  11. Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome

    Ixtaccihuatl H. Obregón, Kelvin C. de Andrade, ... Sharon A. Savage in Familial Cancer
    Article 11 January 2023
  12. Clinical and genetic characteristics of carriers of the TP53 c.541C > T, p.Arg181Cys pathogenic variant causing hereditary cancer in patients of Arab-Muslim descent

    TP53 pathogenic variants cause Li-Fraumeni syndrome (LFS), with some variants causing an attenuated phenotype. Herein, we describe the clinical...

    Johnathan Arnon, Aviad Zick, ... Shiri Shkedi-Rafid in Familial Cancer
    Article Open access 14 May 2024
  13. Chromosomal Instability and Genetic Polymorphism in Miners and Workers of Coal Thermal Power Plants

    Abstract

    Polymorphic variants of genes of enzymes of xenobiotic biotransformation ( CYP1A1 ( rs4646903 ), CYP1A2 ( rs762551 ), CYP2D6 ( rs35742686 ), CYP2E1 ...

    V. I. Minina, Ya. A. Savchenko, ... A. N. Glushkov in Russian Journal of Genetics
    Article 01 April 2020
  14. Integrated analysis identifies GABRB3 as a biomarker in prostate cancer

    Background

    Treatment failure following androgen deprivation therapy (ADT) presents a significant challenge in the management of advanced prostate...

    Jun-Yan Chen, Chi-Fen Chang, ... Bo-Ying Bao in BMC Medical Genomics
    Article Open access 29 January 2024
  15. Inherited alterations of TGF beta signaling components in Appalachian cervical cancers

    Purpose

    This study examined targeted genomic variants of transforming growth factor beta (TGFB) signaling in Appalachian women. Appalachian women with...

    Thomas J. Knobloch, Juan Peng, ... Christopher M. Weghorst in Cancer Causes & Control
    Article 21 August 2019
  16. Single nucleotide polymorphisms and the risk of develo** a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis

    Background

    Head and Neck Cancer (HNC) survivors are at increased risk of develo** a second primary cancer (SPC). Along with the environmental risk...

    Ilda Hoxhaj, Vladimir Vukovic, ... Roberta Pastorino in BMC Cancer
    Article Open access 02 June 2021
  17. Genetic susceptibility of bladder cancer in the Lebanese population

    Background

    Bladder cancer (BC) is the 10 th most frequent tumor worldwide. Evidence shows an association between elevated risk of BC and various...

    Hampig Raphael Kourie, Bahaa Succar, ... Elie Nemr in BMC Medical Genomics
    Article Open access 17 October 2022
  18. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study

    Background

    Cervical cancer is the 4th highest cause of female reproductive tract malignancies. Multiple loci have been identified as important...

    Gui-Cen Liu, Yun-Fei Zhou, ... Jun Zhang in BMC Cancer
    Article Open access 07 January 2019
  19. Role of Genetic Polymorphisms in Breast Cancer

    Of all cancers that affect women, the highest number of deaths results from breast cancer (BC). The tumorigenesis of BC is due to either chromosomal...
    Chapter 2021
  20. DUSP5 and PHLDA1 mutations in mature cystic teratomas of the ovary identified on whole-exome sequencing may explain teratoma characteristics

    Background

    Mature cystic teratomas of the ovary are the most common type of germ cell tumor, comprising 33% of ovarian tumors. Studying these tumors...

    Wen-Chung Wang, Yen-Chein Lai in Human Genomics
    Article Open access 26 October 2022
Did you find what you were looking for? Share feedback.